Absci and MSK Collaborate on Generative AI Drug Discovery
What You Should Know: – Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics. …
Continue Reading